Rapid molecular point of care testing
Ended Awarded Last action
- Contract number
- 36C25925N0267
- Awardee
-
Roche Diagnostics Corporation UEI JDMDFEZBYH36
- Awarding agency
-
Veterans Integrated Service Network 19
Veterans Health Administration, Department of Veterans Affairs
- Obligated
- $143,061
Award facts
- Contract value 100% obligated
- $143,061.20 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Contracting staff
- NAICS code
- 334516 Analytical Laboratory Instrument Manufacturing
- Set-aside
- No set-aside
- Competition
- Competed under SAP · 4 offers Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- Oklahoma City, OK 73104, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Supplemental Agreement for work within scope | -$298,769 | |
| Original award | $441,830 |
About this award
This contract award is a Blanket Purchase Agreement (BPA) call issued by Veterans Integrated Service Network 19 (VISN 19) to Roche Diagnostics Corporation for rapid molecular point-of-care testing services. The award, made on February 24, 2025, carries a ceiling value of $143,061.20 under a firm fixed-price structure with no set-aside designation. The contract will be performed in Oklahoma City, Oklahoma, with an ultimate completion date of January 31, 2026. This BPA call represents a delivery order against an existing indefinite delivery vehicle, leveraging Roche's established relationship with the Department of Veterans Affairs to supply diagnostic testing capabilities to veteran healthcare facilities.
Roche Diagnostics Corporation, a foreign-owned manufacturer headquartered in Indianapolis, Indiana, is a primary federal supplier of in vitro diagnostic equipment, reagents, and testing systems to military and veteran healthcare systems. The company maintains extensive indefinite delivery contracts and blanket purchase agreements across multiple Veterans Integrated Service Networks and the Defense Health Agency, with contract values ranging from hundreds of thousands to several million dollars and extending through 2030. Under this specific call, Roche will deliver rapid molecular point-of-care testing solutions, consistent with the company's portfolio of molecular diagnostic platforms, reagents, and associated support services that enable efficient pathogen detection and clinical decision-making in veteran healthcare settings.
Quick answers
Who was awarded contract 36C25925N0267?
36C25925N0267 was awarded to Roche Diagnostics Corporation by Veterans Integrated Service Network 19 (Veterans Health Administration) on February 24, 2025.
How much is contract 36C25925N0267 worth?
The government has obligated $143,061 on 36C25925N0267.
Is contract 36C25925N0267 an order under another contract?
Yes. 36C25925N0267 is a BPA call under 36C25924A0042, a blanket purchase agreement.
Was contract 36C25925N0267 competed?
The extent of competition for 36C25925N0267 was competed under sap. The government received 4 offers.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award